What is Ehlers-Danlos (EDS) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Ehlers-Danlos syndrome (EDS) is a rare autosomal dominant disorder characterized by easy bruising, thin skin with visible veins, characteristic facial features, and rupture of arteries, uterus, or intestines, with a median survival of only 48 years due to fatal arterial ruptures 1.

Key Characteristics

  • Easy bruising
  • Thin skin with visible veins
  • Characteristic facial features
  • Rupture of arteries, uterus, or intestines

Diagnosis and Management

The diagnosis of vascular Ehlers-Danlos syndrome is based on DNA or protein studies identifying a defect in type III collagen, encoded by the COL3A1 gene 1. Management focuses on preventing fatal complications, such as arterial rupture, and improving quality of life. Noninvasive vascular imaging is preferred to avoid fatal complications associated with invasive imaging in these patients 1.

Pregnancy and Delivery

Pregnancy in women with Ehlers-Danlos syndrome is high-risk due to rupture of the gravid uterus and vessel rupture at delivery or in the postpartum period, and close monitoring is essential 1. Postpartum hemorrhage may be severe, and incisions may heal slowly, requiring retention sutures 1.

Outcome and Prognosis

The outcome of pregnancy in women with Ehlers-Danlos syndrome is poor, and the median survival is only 48 years due to fatal arterial ruptures 1. Early diagnosis and comprehensive management can significantly improve quality of life and prevent complications, and genetic counseling is recommended for family planning 1.

From the Research

Definition and Characteristics of Ehlers-Danlos Syndrome

  • Ehlers-Danlos Syndrome (EDS) is a group of inherited connective tissue disorders characterized by joint hypermobility, skin hyperextensibility, and generalized tissue fragility 2.
  • EDS can present with a variety of types of pain, and the mechanisms and treatments for pain are poorly understood 3.
  • The syndrome comprises a group of diseases characterized by connective tissue fragility, with clinical symptoms primarily involving the skin, joints, blood vessels, and internal organs 2.

Types and Prevalence of Ehlers-Danlos Syndrome

  • Hypermobile EDS (hEDS) is the most common subtype of EDS, characterized by multi-joint pain, particularly in large joints such as the shoulder 4.
  • EDS has a prevalence as high as 1 in 5,000 individuals, predominantly affecting women 4.

Diagnosis and Management of Ehlers-Danlos Syndrome

  • Diagnosing EDS is complicated due to clinical variability, imprecise diagnostic criteria, and lack of physician knowledge about this rare disease 2.
  • Primary practitioners are capable of diagnosing and managing EDS, but few are knowledgeable and comfortable enough to see patients with EDS, resulting in delays in diagnosis and care 5.
  • Providers need clinical practice guidelines, information on their roles in EDS management, and coordination with specialty care to improve diagnosis and care 5.

Treatment and Management of Symptoms

  • Various treatment modalities, including physical therapy, occupational therapy, and complimentary/alternative treatments, have been used to manage EDS symptoms, with varying degrees of success 3.
  • Kinesiology taping (KT) is an inexpensive and relatively safe intervention that can offer temporary improvements in pain and function for patients with EDS and shoulder pain 4.
  • Skin fragility and wound management are critical aspects of EDS care, requiring preventative measures, protective dressings, and careful wound management to avoid further injury 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.